(S)-N-(2-Methoxy-5-((5-(Trifluoromethyl)Pyridin-2-Yl)Oxy)Phenyl)-3-Methyl-2-Oxoimidazolidine-4-Carboxamide

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

4 Countries

Phase I/II

Phase I/II: 1

Sponsors using this IMP

Orion Corporation 1

All trials

1 total

Trial to study the safety and pharmacokinetics of ODM-212 combined with existing cancer treatments Pending

2025-524620-22-00 Phase I/II 4 countries Orion Corporation

Showing 1–1 of 1 trials

← All drugs A–Z